Evidence map›Paper›PMID 41341730›Full record

SynthesisFrontiers in psychology2025

Medical ozone treatment for pain, fatigue, anxiety, and depression in cancer patients: a scoping review.

Lei Lei, Xiaojing Xue, Gang Feng, Xiaoyan Wang, Yuan Jiang

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in psychology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Lei Lei *Department of Oncology, Mianyang Central Hospital Affiliated Hospital of Electronic Science and Technology University, Mianyang, China.
Xiaojing Xue *Department of Oncology, Mianyang Central Hospital Affiliated Hospital of Electronic Science and Technology University, Mianyang, China.
Gang FengDepartment of Oncology, Mianyang Central Hospital Affiliated Hospital of Electronic Science and Technology University, Mianyang, China.
Xiaoyan WangDepartment of Oncology, Mianyang Central Hospital Affiliated Hospital of Electronic Science and Technology University, Mianyang, China.
Yuan JiangDepartment of Oncology, Mianyang Central Hospital Affiliated Hospital of Electronic Science and Technology University, Mianyang, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: The aim of this study is to conduct a scoping review on the application of medical ozone treatment in managing symptoms (including Pain, Fatigue, Anxiety, and Depression) among cancer patients, aiming to provide clinical medical staff with a reference for implementing a novel approach to symptom management. Methods: This scoping review was conducted based on the methodology presented by Arksey and O'Malley and The Joanna Briggs Institute methodology was employed to conduct scoped reviews of Pubmed, Web of science, CINAHL, EMBASE, MEDLINE, APA and CNKI in order to address the research question: "What is the impact of medical ozone treatment on pain, fatigue, anxiety, and depression in cancer patients?" Two independent reviewers select samples by screening and reviewing articles and extract data using a data chart form. The protocol was registered in the Open Science Framework (OSF.). Results: A total of 16 articles were included to analyze and integrate the use of medical ozone, medical ozone dose, symptom assessment tools, and symptom management. Conclusion: The effectiveness of medical ozone treatment in managing key symptoms (including Pain, Fatigue, Anxiety, and Depression) among cancer patients has been preliminarily verified. Future studies need to cover a wider range of areas and larger sample sizes, as well as conduct long-term follow-up studies and multi-dimensional evaluation to enhance the universality and reliability of the results.

Indexed as

cancermedical ozone treatmentozonescoping reviewsymptoms

Identifiers

PMID41341730
PMCPMC12671048

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.